Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast Cancer 10/22/2021 INTERVENTIONAL unchanged 1,769.85 0 A Pilot Study to Evaluate PureWick for Nocturia 10/25/2021 INTERVENTIONAL unchanged 1,766.85 0 Effect of Physical Activity and Pain Education on Endometriosis-associated Pain 10/25/2021 INTERVENTIONAL unchanged 1,766.85 0 St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic 10/25/2021 INTERVENTIONAL unchanged 1,766.85 0 RCT of At-Home tDCS for Depression in Pregnancy 10/28/2021 INTERVENTIONAL unchanged 1,763.85 0 A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital) 10/28/2021 INTERVENTIONAL unchanged 1,763.85 0 Efficacy of Internet-based Cognitive Behavioral Therapy for Endometriosis 10/28/2021 INTERVENTIONAL unchanged 1,763.85 0 Smart Removal for Congenital Diaphragmatic Hernia 10/29/2021 INTERVENTIONAL unchanged 1,762.85 0 Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer 11/01/2021 OBSERVATIONAL unchanged 1,759.85 0 Bempedoic Acid Pregnancy Surveillance Program 11/02/2021 OBSERVATIONAL unchanged 1,758.85 0 Financial Toxicity in Breast Cancer Surgery 11/03/2021 OBSERVATIONAL unchanged 1,757.85 0 Human Milk and Its Effect on Infant's Metabolism and Infant Gut Microbiome 11/08/2021 OBSERVATIONAL unchanged 1,752.85 0 A Study to Evaluate White Matter Hyperintensities in Migraine 11/08/2021 INTERVENTIONAL unchanged 1,752.85 0 Gestational Diabetes - PrEvention of PostPartum Diabetes Study 11/09/2021 INTERVENTIONAL unchanged 1,751.85 0 Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma 11/09/2021 INTERVENTIONAL unchanged 1,751.85 0 Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer 11/09/2021 INTERVENTIONAL unchanged 1,751.85 0 Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer 11/09/2021 INTERVENTIONAL unchanged 1,751.85 0 Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS) 11/09/2021 INTERVENTIONAL unchanged 1,751.85 0 Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients 11/10/2021 INTERVENTIONAL unchanged 1,750.85 0 Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65). 11/10/2021 INTERVENTIONAL unchanged 1,750.85 0 Comparison of Changes in the Quality of Life of Patients Operated on Breast Cancer at the Drôme Ardèche Breast Institute According to Access to Supportive Oncological Care (IDSein) 11/11/2021 OBSERVATIONAL unchanged 1,749.85 0 Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture 11/11/2021 INTERVENTIONAL unchanged 1,749.85 0 Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring 11/15/2021 INTERVENTIONAL unchanged 1,745.85 0 Family Functioning in Obesity Treatment for Mexican Americans 11/15/2021 INTERVENTIONAL unchanged 1,745.85 0 Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV 11/16/2021 INTERVENTIONAL unchanged 1,744.85 0 Maternal & Offspring Microbiome Study 11/17/2021 INTERVENTIONAL unchanged 1,743.85 0 Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) 11/17/2021 INTERVENTIONAL unchanged 1,743.85 0 Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes 11/18/2021 INTERVENTIONAL unchanged 1,742.85 0 Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive 11/19/2021 OBSERVATIONAL unchanged 1,741.85 0 A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer 11/22/2021 INTERVENTIONAL unchanged 1,738.85 0 Registry Platform Ovarian and Endometrial Cancer 11/22/2021 OBSERVATIONAL unchanged 1,738.85 0 CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing 11/23/2021 INTERVENTIONAL unchanged 1,737.85 0 A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery 11/23/2021 INTERVENTIONAL unchanged 1,737.85 0 Post-operative Cesarean Trial of Pain Control 11/23/2021 INTERVENTIONAL unchanged 1,737.85 0 Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer 11/24/2021 INTERVENTIONAL unchanged 1,736.85 0 Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment 11/24/2021 INTERVENTIONAL unchanged 1,736.85 0 AN/BN Risk Factors Study 11/24/2021 OBSERVATIONAL unchanged 1,736.85 0 De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You 11/26/2021 OBSERVATIONAL unchanged 1,734.85 0 Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia 12/01/2021 INTERVENTIONAL unchanged 1,729.85 0 Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer 12/01/2021 INTERVENTIONAL unchanged 1,729.85 0 Conservative Management for PAS Pilot 12/01/2021 INTERVENTIONAL unchanged 1,729.85 0 Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy 12/02/2021 INTERVENTIONAL unchanged 1,728.85 0 Palliation in Gynae-oncology: Patients Expectations and Assessment of Care (PEACE) 12/02/2021 OBSERVATIONAL unchanged 1,728.85 0 Screening For BCRL In Targeted Therapy For Breast Cancer 12/03/2021 OBSERVATIONAL unchanged 1,727.85 0 Sickle Cell Disease Obstetric Multi-Disciplinary Care Programme 12/03/2021 OBSERVATIONAL unchanged 1,727.85 0 Twin Pregnancy Cohort 12/03/2021 OBSERVATIONAL unchanged 1,727.85 0 A Study to Reduce Persistent Post-mastectomy Pain Using Opioid-free Anesthesia 12/07/2021 INTERVENTIONAL unchanged 1,723.85 0 A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma 12/07/2021 INTERVENTIONAL unchanged 1,723.85 0 Investigation of PEMF Therapy for Female Patients With IC/BPS 12/08/2021 INTERVENTIONAL unchanged 1,722.85 0 Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer 12/09/2021 INTERVENTIONAL unchanged 1,721.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology